An update on immunotherapy in uro-oncology-Reference-Cited by-同舟云学术

An update on immunotherapy in uro-oncology

Published:2021-05-03 Issue:4 Volume:6 Page:229-233
ISSN:2380-8993
Container-title:Expert Review of Precision Medicine and Drug Development
language:en
Short-container-title:Expert Review of Precision Medicine and Drug Development

Author:

Cimadamore Alessia¹,Rizzo Alessandro²,Mollica Veronica²,Massari Francesco²,Lopez-Beltran Antonio³,Scarpelli Marina¹,Cheng Liang⁴,Santoni Matteo⁵,Montironi Rodolfo¹

Affiliation:

1. Section of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, United Hospitals, Ancona, Italy

2. Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy

3. Department of Surgery, Cordoba University Medical School, Cordoba, Spain

4. Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, USA

5. Oncology department, Macerata Hospital, Macerata, Italy

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/23808993.2021.1911638

Reference33 articles.

1. PD1/PD-L1 Axis in Uro-oncology

2. Basis of PD1/PD-L1 Therapies

3. Status of Programmed Death Ligand 1 (PD-L1) by Immunohistochemistry and Scoring Algorithms

4. Predictive biomarkers for immunotherapy in the treatment of advanced urothelial carcinoma: where we stand and where we go

5. FDA Approval Summary: Atezolizumab or Pembrolizumab for the Treatment of Patients with Advanced Urothelial Carcinoma Ineligible for Cisplatin-Containing Chemotherapy

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical utility of checkpoint inhibitors against metastatic bladder cancer: overcoming challenges to find a way forward;Expert Opinion on Biological Therapy;2023-04-10

2. The 2022 revision of the World Health Organization classification of tumors of the urinary system and male genital organs: advances and challenges;Human Pathology;2022-09